{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:49:23Z","timestamp":1784598563740,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R37-DA15612"],"award-info":[{"award-number":["R37-DA15612"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Care Manag Sci"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10729-023-09657-0","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T13:01:51Z","timestamp":1696683711000},"page":"599-603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Responding to the US opioid crisis: leveraging analytics to support decision making"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-8920","authenticated-orcid":false,"given":"Margaret L.","family":"Brandeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,7]]},"reference":[{"key":"9657_CR1","unstructured":"Centers for Disease Control and Prevention (2023) The drug overdose epidemic: behind the numbers. Available at https:\/\/www.cdc.gov\/opioids\/data\/index.html"},{"key":"9657_CR2","unstructured":"Centers for Disease Control and Prevention (2023) Provisional data shows U.S. drug overdose deaths top 100,000 in 2022. Available at https:\/\/blogs.cdc.gov\/nchs\/2023\/05\/18\/7365\/"},{"key":"9657_CR3","unstructured":"National Institute on Drug Abuse (2023) Drug overdose death rates. Available at https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates"},{"key":"9657_CR4","unstructured":"Statistica (2023) Number of military fatalities in all major wars involving the United States from 1775 to 2023. Available at https:\/\/www.statista.com\/statistics\/1009819\/total-us-military-fatalities-in-american-wars-1775-present\/"},{"key":"9657_CR5","doi-asserted-by":"publisher","first-page":"eaau1184","DOI":"10.1126\/science.aau1184","volume":"361","author":"H Jalal","year":"2018","unstructured":"Jalal H, Buchanich JM, Roberts MS et al (2018) Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science 361:eaau1184. https:\/\/doi.org\/10.1126\/science.aau1184","journal-title":"Science"},{"key":"9657_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41591-020-0855-y","volume":"26","author":"H Jalal","year":"2020","unstructured":"Jalal H, Buchanich JM, Sinclair DR, Roberts MS, Burke DS (2020) Age and generational patterns of overdose death risk from opioids and other drugs. Nat Med 26:699\u2013704. https:\/\/doi.org\/10.1038\/s41591-020-0855-y","journal-title":"Nat Med"},{"key":"9657_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugpo.2017.06.003","volume":"46","author":"GJ Unick","year":"2017","unstructured":"Unick GJ, Ciccarone D (2017) US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations. Int J Drug Policy 46:112\u2013119. https:\/\/doi.org\/10.1016\/j.drugpo.2017.06.003","journal-title":"Int J Drug Policy"},{"key":"9657_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamapsychiatry.2022.2284","volume":"79","author":"CM Jones","year":"2022","unstructured":"Jones CM, Shoff C, Hodges K et al (2022) Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and during the COVID-19 pandemic. JAMA Psychiatry 79:981\u2013992. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.2284","journal-title":"JAMA Psychiatry"},{"key":"9657_CR9","doi-asserted-by":"publisher","first-page":"e231235","DOI":"10.1001\/jamahealthforum.2023.1235","volume":"4","author":"RA Harris","year":"2023","unstructured":"Harris RA, Long JA, Bao Y, Mandell DS (2023) Racial, ethnic, and sex differences in methadone-involved overdose deaths before and after the US Federal policy change expanding take-home methadone doses. JAMA Health Forum 4:e231235. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.1235","journal-title":"JAMA Health Forum"},{"key":"9657_CR10","doi-asserted-by":"publisher","first-page":"e231018","DOI":"10.1001\/jamahealthforum.2023.1018","volume":"4","author":"VA Palzes","year":"2023","unstructured":"Palzes VA, Chi FW, Metz VE et al (2023) Overall and telehealth addiction treatment utilization by age, race, ethnicity, and socioeconomic status in California after COVID-19 policy changes. JAMA Health Forum 4:e231018. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.1018","journal-title":"JAMA Health Forum"},{"key":"9657_CR11","doi-asserted-by":"publisher","first-page":"e2252381","DOI":"10.1001\/jamanetworkopen.2022.52381","volume":"6","author":"R Hailu","year":"2023","unstructured":"Hailu R, Mehrotra A, Huskamp HA, Busch AB, Barnett ML (2023) Telemedicine use and quality of opioid use disorder treatment in the US during the COVID-19 pandemic. JAMA Netw Open 6:e2252381. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.52381","journal-title":"JAMA Netw Open"},{"key":"9657_CR12","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1111\/add.15458","volume":"116","author":"P Reuter","year":"2021","unstructured":"Reuter P, Caulkins JP, Midgette G (2021) Heroin use cannot be measured adequately with a general population survey. Addiction 116:2600\u20132609. https:\/\/doi.org\/10.1111\/add.15458","journal-title":"Addiction"},{"key":"9657_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13445","author":"M Tatar","year":"2023","unstructured":"Tatar M, Faraji MR, Keyes K, Wilson FA, Jalali MS (2023) Social vulnerability predictors of drug poisoning mortality: a machine learning analysis in the United States. Am J Addict Epub Ahead of Print. https:\/\/doi.org\/10.1111\/ajad.13445","journal-title":"Am J Addict Epub Ahead of Print"},{"key":"9657_CR14","doi-asserted-by":"publisher","unstructured":"Keyes KM, Rutherford C, Hamilton A et al (2022) What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug Alcohol Depend Rep 3. https:\/\/doi.org\/10.1016\/j.dadr.2022.100052","DOI":"10.1016\/j.dadr.2022.100052"},{"key":"9657_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jrsssa\/qnac013","volume":"186","author":"SA Hepler","year":"2023","unstructured":"Hepler SA, Kline DM, Bonny A, McKnight E, Waller LA (2023) An integrated abundance model for estimating county-level prevalence of opioid misuse in Ohio. J R Stat Soc Ser a Stat Soc 186:43\u201360. https:\/\/doi.org\/10.1093\/jrsssa\/qnac013","journal-title":"J R Stat Soc Ser a Stat Soc"},{"key":"9657_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.annepidem.2023.01.009","volume":"79","author":"H Lu","year":"2023","unstructured":"Lu H, Crawford FW, Gonsalves GS, Grau LE (2023) Geographic and temporal trends in fentanyl-detected deaths in Connecticut, 2009\u20132019. Ann Epidemiol 79:32\u201338. https:\/\/doi.org\/10.1016\/j.annepidem.2023.01.009","journal-title":"Ann Epidemiol"},{"key":"9657_CR17","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1002\/sim.9420","volume":"41","author":"M Fairley","year":"2022","unstructured":"Fairley M, Rao IJ, Brandeau ML, Qian GL, Gonsalves GS (2022) Surveillance for endemic infectious disease outbreaks: adaptive sampling using profile likelihood estimation. Stat Med 41:3336\u20133348. https:\/\/doi.org\/10.1002\/sim.9420","journal-title":"Stat Med"},{"key":"9657_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugpo.2016.02.003","volume":"31","author":"JP Caulkins","year":"2016","unstructured":"Caulkins JP, Disley E, Tzvetkova M et al (2016) Modeling the structure and operation of drug supply chains: the case of cocaine and heroin in Italy and Slovenia. Int J Drug Policy 31:64\u201373. https:\/\/doi.org\/10.1016\/j.drugpo.2016.02.003","journal-title":"Int J Drug Policy"},{"key":"9657_CR19","doi-asserted-by":"publisher","first-page":"e2115714119","DOI":"10.1073\/pnas.2115714119","volume":"119","author":"TY Lim","year":"2022","unstructured":"Lim TY, Stringfellow EJ, Stafford CA et al (2022) Modeling the evolution of the US opioid crisis for national policy development. Proc Natl Acad Sci U S A 119:e2115714119. https:\/\/doi.org\/10.1073\/pnas.2115714119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9657_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10729-022-09605-4","volume":"25","author":"MV Bjarnadottir","year":"2022","unstructured":"Bjarnadottir MV, Anderson DB, Agarwal R, Nelson DA (2022) Aiding the prescriber: developing a machine learning approach to personalized risk modeling for chronic opioid therapy amongst US Army soldiers. Health Care Manag Sci 25:649\u2013665. https:\/\/doi.org\/10.1007\/s10729-022-09605-4","journal-title":"Health Care Manag Sci"},{"key":"9657_CR21","doi-asserted-by":"publisher","first-page":"e2248559","DOI":"10.1001\/jamanetworkopen.2022.48559","volume":"5","author":"V Sharma","year":"2022","unstructured":"Sharma V, Kulkarni V, Jess E et al (2022) Development and validation of a machine learning model to estimate risk of adverse outcomes within 30 days of opioid dispensation. JAMA Netw Open 5:e2248559. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.48559","journal-title":"JAMA Netw Open"},{"key":"9657_CR22","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2105\/AJPH.2018.304590","volume":"108","author":"AL Pitt","year":"2018","unstructured":"Pitt AL, Humphreys K, Brandeau ML (2018) Modeling health benefits and harms of public policy responses to the US opioid epidemic. Am J Public Health 108:1394\u20131400. https:\/\/doi.org\/10.2105\/AJPH.2018.304590","journal-title":"Am J Public Health"},{"key":"9657_CR23","doi-asserted-by":"publisher","first-page":"100031","DOI":"10.1016\/j.lana.2021.100031","volume":"3","author":"IJ Rao","year":"2021","unstructured":"Rao IJ, Humphreys K, Brandeau ML (2021) Effectiveness of policies for controlling the US opioid epidemic: a model-based analysis from the Stanford-Lancet Commission on the North American Opioid Crisis. Lancet Reg Health - Americas 3:100031. https:\/\/doi.org\/10.1016\/j.lana.2021.100031","journal-title":"Lancet Reg Health - Americas"},{"key":"9657_CR24","doi-asserted-by":"publisher","first-page":"103953","DOI":"10.1016\/j.drugpo.2023.103953","volume":"112","author":"S Kim","year":"2023","unstructured":"Kim S, Suh HS (2023) A population-based study on the risk of prescription opioid abuse in patients with chronic opioid use and cost-effectiveness of prescription drug monitoring program using a patient simulation model in South Korea. Int J Drug Policy 112:103953. https:\/\/doi.org\/10.1016\/j.drugpo.2023.103953","journal-title":"Int J Drug Policy"},{"key":"9657_CR25","doi-asserted-by":"publisher","first-page":"7784","DOI":"10.1073\/pnas.1812459116","volume":"116","author":"NR Magliocca","year":"2019","unstructured":"Magliocca NR, McSweeney K, Sesnie SE et al (2019) Modeling cocaine traffickers and counterdrug interdiction forces as a complex adaptive system. Proc Natl Acad Sci U S A 116:7784\u20137792. https:\/\/doi.org\/10.1073\/pnas.1812459116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9657_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1287\/opre.49.3.352.11215","volume":"49","author":"G Tragler","year":"2001","unstructured":"Tragler G, Caulkins JP, Feichtinger G (2001) Optimal dynamic allocation of treatment and enforcement in illicit drug control. Oper Res 49:352\u2013362. https:\/\/doi.org\/10.1287\/opre.49.3.352.11215","journal-title":"Oper Res"},{"key":"9657_CR27","doi-asserted-by":"publisher","DOI":"10.2307\/j.ctvpr7rb2","volume-title":"Deaths of despair and the future of capitalism","author":"A Case","year":"2020","unstructured":"Case A, Deaton A (2020) Deaths of despair and the future of capitalism. Princeton University Press, Princeton, NJ"},{"key":"9657_CR28","doi-asserted-by":"publisher","first-page":"e237036","DOI":"10.1001\/jamanetworkopen.2023.7036","volume":"6","author":"A Chatterjee","year":"2023","unstructured":"Chatterjee A, Weitz M, Savinkina A et al (2023) Estimated costs and outcomes associated with use and nonuse of medications for opioid use disorder during incarceration and at release in Massachusetts. JAMA Netw Open 6:e237036. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.7036","journal-title":"JAMA Netw Open"},{"key":"9657_CR29","doi-asserted-by":"publisher","first-page":"e231080","DOI":"10.1001\/jamahealthforum.2023.1080","volume":"4","author":"AL Claypool","year":"2023","unstructured":"Claypool AL, DiGennaro C, Russell WA et al (2023) Cost-effectiveness of increasing buprenorphine treatment initiation, duration, and capacity among individuals who use opioids. JAMA Health Forum 4:e231080. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.1080","journal-title":"JAMA Health Forum"},{"key":"9657_CR30","doi-asserted-by":"publisher","first-page":"109893","DOI":"10.1016\/j.drugalcdep.2023.109893","volume":"247","author":"B Enns","year":"2023","unstructured":"Enns B, Krebs E, Whitehurst DGT et al (2023) Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder. Drug Alcohol Depend 247:109893. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109893","journal-title":"Drug Alcohol Depend"},{"key":"9657_CR31","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamapsychiatry.2021.0247","volume":"78","author":"M Fairley","year":"2021","unstructured":"Fairley M, Humphreys K, Joyce VR et al (2021) Cost-effectiveness of treatments for opioid use disorder. JAMA Psychiatry 78:767\u2013777. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0247","journal-title":"JAMA Psychiatry"},{"key":"9657_CR32","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2105\/ajph.90.7.1100","volume":"90","author":"GS Zaric","year":"2000","unstructured":"Zaric GS, Barnett PG, Brandeau ML (2000) HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health 90:1100\u20131111. https:\/\/doi.org\/10.2105\/ajph.90.7.1100","journal-title":"Am J Public Health"},{"key":"9657_CR33","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1177\/0272989X11412975","volume":"31","author":"DO Meltzer","year":"2011","unstructured":"Meltzer DO, Hoomans T, Chung JW, Basu A (2011) Minimal modeling approaches to value of information analysis for health research. Med Decis Making 31:E1\u2013E22. https:\/\/doi.org\/10.1177\/0272989X11412975","journal-title":"Med Decis Making"},{"key":"9657_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","volume":"45","author":"AR Williams","year":"2019","unstructured":"Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M (2019) Development of a Cascade of Care for responding to the opioid epidemic. Am J Drug Alcohol Abuse 45:1\u201310. https:\/\/doi.org\/10.1080\/00952990.2018.1546862","journal-title":"Am J Drug Alcohol Abuse"},{"key":"9657_CR35","doi-asserted-by":"publisher","first-page":"100258","DOI":"10.1016\/j.orhc.2020.100258","volume":"25","author":"JG Barrow","year":"2020","unstructured":"Barrow JG, Fairley M, Brandeau ML (2020) Optimizing interventions across the HIV care continuum: process improvement analysis. Oper Res Health Care 25:100258. https:\/\/doi.org\/10.1016\/j.orhc.2020.100258","journal-title":"Oper Res Health Care"},{"key":"9657_CR36","unstructured":"Singer JA (2023) Overdose prevention centers: a successful strategy for preventing death and disease. Cato Institute. https:\/\/www.cato.org\/briefing-paper\/overdose-prevention-centers-successful-strategy-preventing-death-disease"},{"key":"9657_CR37","doi-asserted-by":"publisher","first-page":"e2241174","DOI":"10.1001\/jamanetworkopen.2022.41174","volume":"5","author":"X Zang","year":"2022","unstructured":"Zang X, Bessey SE, Krieger MS et al (2022) Comparing projected fatal overdose outcomes and costs of strategies to expand community-based distribution of naloxone in Rhode Island. JAMA Netw Open 5:e2241174. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.41174","journal-title":"JAMA Netw Open"},{"key":"9657_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1287\/inte.23.1.7","volume":"23","author":"EH Kaplan","year":"1993","unstructured":"Kaplan EH, O\u2019Keefe E (1993) Let the needles do the talking! Evaluating the New Haven Needle Exchange. Interfaces 23:7\u201326. https:\/\/doi.org\/10.1287\/inte.23.1.7","journal-title":"Interfaces"},{"key":"9657_CR39","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1503\/cmaj.080808","volume":"179","author":"AM Bayoumi","year":"2008","unstructured":"Bayoumi AM, Zaric GS (2008) The cost-effectiveness of Vancouver\u2019s supervised injection facility. CMAJ 179:1143\u20131151. https:\/\/doi.org\/10.1503\/cmaj.080808","journal-title":"CMAJ"},{"key":"9657_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/00952990.2020.1755677","volume":"47","author":"J Homer","year":"2021","unstructured":"Homer J, Wakeland W (2021) A dynamic model of the opioid drug epidemic with implications for policy. Am J Drug Alcohol Abuse 47:5\u201315. https:\/\/doi.org\/10.1080\/00952990.2020.1755677","journal-title":"Am J Drug Alcohol Abuse"},{"key":"9657_CR41","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/add.15833","volume":"117","author":"K Abel-Ollo","year":"2022","unstructured":"Abel-Ollo K (2022) What lessons from Estonia\u2019s experience could be applied in the United States in response to the addiction and overdose crisis? Addiction 117:1188\u20131189. https:\/\/doi.org\/10.1111\/add.15833","journal-title":"Addiction"},{"key":"9657_CR42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.drugalcdep.2008.03.008","volume":"96","author":"AS Buchanan","year":"2008","unstructured":"Buchanan AS, Latkin CA (2008) Drug use in the social networks of heroin and cocaine users before and after drug cessation. Drug Alcohol Depend 96:286\u2013289. https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.03.008","journal-title":"Drug Alcohol Depend"},{"key":"9657_CR43","unstructured":"Substance Abuse and Mental Health Services Administration (2020) Leveraging Existing Health and Disease Management Programs to Provide Mental Health and Substance Use Disorder Resources During the COVID-19 Public Health Emergency (PHE). Available at https:\/\/www.samhsa.gov\/coronavirus"},{"key":"9657_CR44","unstructured":"Substance Abuse and Mental Health Services Administration (2020) Methadone Take-Home Flexibilities Extension Guidance. Available at https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/statutes-regulations-guidelines\/methadone-guidance"},{"key":"9657_CR45","doi-asserted-by":"publisher","first-page":"109762","DOI":"10.1016\/j.drugalcdep.2022.109762","volume":"243","author":"G Qian","year":"2023","unstructured":"Qian G, Rao IJ, Humphreys K, Owens DK, Brandeau ML (2023) Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder. Drug Alcohol Depend 243:109762. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109762","journal-title":"Drug Alcohol Depend"},{"key":"9657_CR46","unstructured":"United Nations AIDS, Programme (2016) UNAIDS urges countries to adopt a people-, rights- and health-centred approach to reverse the HIV epidemic among people who inject drugs. UNAIDS. Available at http:\/\/www.unaids.org\/en\/resources\/presscentre\/pressreleaseandstatementarchive\/2016\/april\/20160415_UNGASS"},{"key":"9657_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-criminol-061020-125715","volume":"4","author":"JP Caulkins","year":"2021","unstructured":"Caulkins JP, Gould A, Pardo B, Reuter P, Stein BD (2021) Opioids and the criminal justice system: new challenges posed by the modern opioid epidemic. Ann Rev Criminology 4:353\u2013375. https:\/\/doi.org\/10.1146\/annurev-criminol-061020-125715","journal-title":"Ann Rev Criminology"},{"key":"9657_CR48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(21)02252-2","volume":"399","author":"K Humphreys","year":"2022","unstructured":"Humphreys K, Shover CL, Andrews CM et al (2022) Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. Lancet 399:555\u2013604. https:\/\/doi.org\/10.1016\/S0140-6736(21)02252-2","journal-title":"Lancet"},{"key":"9657_CR49","doi-asserted-by":"publisher","first-page":"1003239","DOI":"10.1371\/journal.pmed.1003239","volume":"17","author":"CM Bernard","year":"2020","unstructured":"Bernard CM, Rao IJ, Robison KK, Brandeau ML (2020) Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: a model-based analysis. PLoS Med 17:1003239. https:\/\/doi.org\/10.1371\/journal.pmed.1003239","journal-title":"PLoS Med"},{"key":"9657_CR50","volume-title":"A bayesian meta-analysis of drug court cost-effectiveness","author":"PM Downey","year":"2010","unstructured":"Downey PM, Roman J (2010) A Bayesian meta-analysis of drug court cost-effectiveness. District of Columbia Crime Policy Institute, Washington, DC"},{"key":"9657_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0193841X03257531","volume":"28","author":"M Shanahan","year":"2004","unstructured":"Shanahan M, Lancsar E, Haas M et al (2004) Cost-effectiveness analysis of the New South Wales adult drug court program. Eval Rev 28:3\u201327. https:\/\/doi.org\/10.1177\/0193841X03257531","journal-title":"Eval Rev"}],"container-title":["Health Care Management Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-023-09657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10729-023-09657-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-023-09657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T13:09:55Z","timestamp":1702040995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10729-023-09657-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,7]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["9657"],"URL":"https:\/\/doi.org\/10.1007\/s10729-023-09657-0","relation":{},"ISSN":["1386-9620","1572-9389"],"issn-type":[{"value":"1386-9620","type":"print"},{"value":"1572-9389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,7]]},"assertion":[{"value":"11 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no competing financial or other interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}